Clostridium Difficile Colitis

Marylise Boutros(Jewish General Hospital), Jeffrey Barkun(McGill University), Peter Ghali(Royal Victoria Regional Health Centre), Steven Paraskevas(McGill University Health Centre), Gabriel Chan(McGill University Health Centre), Mazen Hassanain(King Saud University), Peter Metrakos(McGill University Health Centre), Jean Tchervenkov(McGill University Health Centre), Marc Deschênes(McGill University Health Centre), Marcelo Cantarovich(McGill University Health Centre), Renzo Cecere(McGill University Health Centre), Elham Rahme(McGill University), Nadia Giannetti(Inserm), Philip Wong(University of California, Santa Barbara), Maha Al-Shaibi(McGill University Health Centre), Myriam Fernández(McGill University Health Centre), Prosanto Chaudhury(McGill University Health Centre)
Transplantation
March 23, 2012
10.1097/tp.0b013e31824d34de
Cited by 122

Related Papers

Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
|Hepatology|2014|2k
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
|European Heart Journal|2020|179
Chylous Ascites: Evaluation and Management
|ISRN Hepatology|2014|171
Management of Chronic Hepatitis C: Consensus Guidelines
|Canadian Journal of Gastroenterology|2007|141